Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low Dose TBI and Fludarabine with Allo-SCT for Hematologic Malignancies
NCT00044954Phase 2Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- Nov 1999
- Primary completion
- Nov 2006
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of fludarabine in Chronic Myeloid Leukemia (CML), acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), multiple myeloma (MM), Hodgkin lymphoma (HL), sponsored by UT Southwestern Medical Center. Started Nov 1999; status: completed.
02
Drugs
fludarabine
03
Conditions
Chronic Myeloid Leukemia (CML)acute myeloid leukemia (AML)myelodysplastic syndrome (MDS)multiple myeloma (MM)Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT00044954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00044954.